Antifungal Tc17 cells are durable and stable, persisting as long-lasting vaccine memory without plasticity towards IFNγ cells

PLoS Pathogens

Volumn 13, Issue 5, 2017, Pages

  Nanjappa, Som Gowda ^a   McDermott, Andrew J ^a   Fites, J Scott ^a   Galles, Kevin ^a   Wüthrich, Marcel ^a   Deepe, George S ^b   Klein, Bruce S ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ECHINOMYCIN; FUNGUS VACCINE; GAMMA INTERFERON; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 17; MIMOSINE; PROTEIN BCL 2; PROTEIN BCL XL; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR 7; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TUMOR NECROSIS FACTOR; VENETOCLAX;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PLASTICITY; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; FLOW CYTOMETRY; MEMORY T LYMPHOCYTE; MOUSE; MYCOSIS; NONHUMAN; TC1 CELL; TC17 CELL; TH17 CELL; VACCINATION; ANIMAL; BLASTOMYCES; BLASTOMYCOSIS; C57BL MOUSE; CYTOLOGY; HUMAN; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; MICROBIOLOGY; PATHOPHYSIOLOGY;

ANIMALS; BLASTOMYCES; BLASTOMYCOSIS; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; FUNGAL VACCINES; HUMANS; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; MICE, INBRED C57BL; TH17 CELLS;

EID: 85020191814     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006356     Document Type: Article

References (65)

1. Seder RA, Ahmed R, (2003) Similarities and differences in CD4+ and CD8+ effector and memory T cell generation. Nat Immunol4: 835–842. doi: 10.1038/ni969 12942084
2. Miller JD, van der Most RG, Akondy RS, Glidewell JT, Albott S, et al. (2008) Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines. Immunity28: 710–722. doi: 10.1016/j.immuni.2008.02.020 18468462
3. Murali-Krishna K, Lau LL, Sambhara S, Lemonnier F, Altman J, et al. (1999) Persistence of memory CD8 T cells in MHC class I-deficient mice. Science286: 1377–1381. 10558996
4. Hammarlund E, Lewis MW, Hansen SG, Strelow LI, Nelson JA, et al. (2003) Duration of antiviral immunity after smallpox vaccination. Nat Med9: 1131–1137. doi: 10.1038/nm917 12925846
5. Surh CD, Sprent J, (2008) Homeostasis of naive and memory T cells. Immunity29: 848–862. doi: 10.1016/j.immuni.2008.11.002 19100699
6. Ku CC, Murakami M, Sakamoto A, Kappler J, Marrack P, (2000) Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science288: 675–678. 10784451
7. Schluns KS, Kieper WC, Jameson SC, Lefrancois L, (2000) Interleukin-7 mediates the homeostasis of naive and memory CD8 T cells in vivo. Nat Immunol1: 426–432. doi: 10.1038/80868 11062503
8. Kaech SM, Tan JT, Wherry EJ, Konieczny BT, Surh CD, et al. (2003) Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells. Nat Immunol4: 1191–1198. doi: 10.1038/ni1009 14625547
9. Kaech SM, Cui W, (2012) Transcriptional control of effector and memory CD8+ T cell differentiation. Nat Rev Immunol12: 749–761. doi: 10.1038/nri3307 23080391
10. Lefrancois L, Marzo AL, (2006) The descent of memory T-cell subsets. Nat Rev Immunol6: 618–623. doi: 10.1038/nri1866 16868553
11. Haines CJ, Chen Y, Blumenschein WM, Jain R, Chang C, et al. (2013) Autoimmune memory T helper 17 cell function and expansion are dependent on interleukin-23. Cell Rep3: 1378–1388. doi: 10.1016/j.celrep.2013.03.035 23623497
12. Kryczek I, Zhao E, Liu Y, Wang Y, Vatan L, et al. (2011) Human TH17 cells are long-lived effector memory cells. Sci Transl Med3: 104ra100. doi: 10.1126/scitranslmed.3002949 21998407
13. Muranski P, Borman ZA, Kerkar SP, Klebanoff CA, Ji Y, et al. (2011) Th17 cells are long lived and retain a stem cell-like molecular signature. Immunity35: 972–985. doi: 10.1016/j.immuni.2011.09.019 22177921
14. Martin-Orozco N, Muranski P, Chung Y, Yang XO, Yamazaki T, et al. (2009) T helper 17 cells promote cytotoxic T cell activation in tumor immunity. Immunity31: 787–798. doi: 10.1016/j.immuni.2009.09.014 19879162
15. Pepper M, Linehan JL, Pagan AJ, Zell T, Dileepan T, et al. (2010) Different routes of bacterial infection induce long-lived TH1 memory cells and short-lived TH17 cells. Nat Immunol11: 83–89. doi: 10.1038/ni.1826 19935657
16. Lindenstrom T, Woodworth J, Dietrich J, Aagaard C, Andersen P, et al. (2012) Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset. Infect Immun80: 3533–3544. doi: 10.1128/IAI.00550-12 22851756
17. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, et al. (2011) Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol12: 255–263. doi: 10.1038/ni.1993 21278737
18. Hernandez-Santos N, Huppler AR, Peterson AC, Khader SA, McKenna KC, et al. (2013) Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections. Mucosal Immunol6: 900–910. doi: 10.1038/mi.2012.128 23250275
19. Miossec P, Kolls JK, (2012) Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov11: 763–776. doi: 10.1038/nrd3794 23023676
20. Yang BH, Floess S, Hagemann S, Deyneko IV, Groebe L, et al. (2015) Development of a unique epigenetic signature during in vivo Th17 differentiation. Nucleic Acids Res43: 1537–1548. doi: 10.1093/nar/gkv014 25593324
21. Mukasa R, Balasubramani A, Lee YK, Whitley SK, Weaver BT, et al. (2010) Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity32: 616–627. doi: 10.1016/j.immuni.2010.04.016 20471290
22. Lee YK, Turner H, Maynard CL, Oliver JR, Chen D, et al. (2009) Late developmental plasticity in the T helper 17 lineage. Immunity30: 92–107. doi: 10.1016/j.immuni.2008.11.005 19119024
23. Muranski P, Restifo NP, (2013) Essentials of Th17 cell commitment and plasticity. Blood121: 2402–2414. doi: 10.1182/blood-2012-09-378653 23325835
24. Nurieva R, Yang XXO, Chung Y, Dong C, (2009) Cutting Edge: In Vitro Generated Th17 Cells Maintain Their Cytokine Expression Program in Normal but Not Lymphopenic Hosts. Journal of Immunology182: 2565–2568.
25. Duhen R, Glatigny S, Arbelaez CA, Blair TC, Oukka M, et al. (2013) Cutting edge: the pathogenicity of IFN-gamma-producing Th17 cells is independent of T-bet. J Immunol190: 4478–4482. doi: 10.4049/jimmunol.1203172 23543757
26. El-Behi M, Ciric B, Dai H, Yan Y, Cullimore M, et al. (2011) The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF. Nat Immunol12: 568–575. doi: 10.1038/ni.2031 21516111
27. Zielinski CE, Mele F, Aschenbrenner D, Jarrossay D, Ronchi F, et al. (2012) Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature484: 514–518. doi: 10.1038/nature10957 22466287
28. Liang Y, Pan HF, Ye DQ, (2015) Tc17 Cells in Immunity and Systemic Autoimmunity. Int Rev Immunol34: 318–331. doi: 10.3109/08830185.2014.954698 25259411
29. Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, et al. (2009) Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol182: 3469–3481. doi: 10.4049/jimmunol.0801814 19265125
30. Nanjappa SG, Heninger E, Wuthrich M, Gasper DJ, Klein BS, (2012) Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog8: e1002771. doi: 10.1371/journal.ppat.1002771 22829762
31. Yeh N, Glosson NL, Wang N, Guindon L, McKinley C, et al. (2010) Tc17 cells are capable of mediating immunity to vaccinia virus by acquisition of a cytotoxic phenotype. J Immunol185: 2089–2098. doi: 10.4049/jimmunol.1000818 20624947
32. Huber M, Heink S, Pagenstecher A, Reinhard K, Ritter J, et al. (2013) IL-17A secretion by CD8+ T cells supports Th17-mediated autoimmune encephalomyelitis. J Clin Invest123: 247–260. doi: 10.1172/JCI63681 23221338
33. Tajima M, Wakita D, Satoh T, Kitamura H, Nishimura T, (2011) IL-17/IFN-gamma double producing CD8+ T (Tc17/IFN-gamma) cells: a novel cytotoxic T-cell subset converted from Tc17 cells by IL-12. Int Immunol23: 751–759. doi: 10.1093/intimm/dxr086 22039016
34. Gartlan KH, Markey KA, Varelias A, Bunting MD, Koyama M, et al. (2015) Tc17 cells are a proinflammatory, plastic lineage of pathogenic CD8+ T cells that induce GVHD without antileukemic effects. Blood126: 1609–1620. doi: 10.1182/blood-2015-01-622662 26206951
35. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, et al. (2012) Hidden killers: human fungal infections. Sci Transl Med4: 165rv113.
36. Nanjappa SG, Heninger E, Wuthrich M, Sullivan T, Klein B, (2012) Protective antifungal memory CD8(+) T cells are maintained in the absence of CD4(+) T cell help and cognate antigen in mice. J Clin Invest122: 987–999. doi: 10.1172/JCI58762 22354169
37. Patel DD, Kuchroo VK, (2015) Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic Interventions. Immunity43: 1040–1051. doi: 10.1016/j.immuni.2015.12.003 26682981
38. Wuthrich M, Gern B, Hung CY, Ersland K, Rocco N, et al. (2011) Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice. J Clin Invest121: 554–568. doi: 10.1172/JCI43984 21206087
39. Nanjappa SG, Hernandez-Santos N, Galles K, Wuthrich M, Suresh M, et al. (2015) Intrinsic MyD88-Akt1-mTOR Signaling Coordinates Disparate Tc17 and Tc1 Responses during Vaccine Immunity against Fungal Pneumonia. PLoS Pathog11: e1005161. doi: 10.1371/journal.ppat.1005161 26367276
40. Wuthrich M, Filutowicz HI, Warner T, Deepe GS, Jr.Klein BS, (2003) Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med197: 1405–1416. doi: 10.1084/jem.20030109 12782709
41. Wei L, Laurence A, Elias KM, O'Shea JJ, (2007) IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner. Journal of Biological Chemistry282: 34605–34610. doi: 10.1074/jbc.M705100200 17884812
42. Hanninen A, Maksimow M, Alam C, Morgan DJ, Jalkanen S, (2011) Ly6C supports preferential homing of central memory CD8+ T cells into lymph nodes. Eur J Immunol41: 634–644. doi: 10.1002/eji.201040760 21308682
43. Joshi NS, Kaech SM, (2008) Effector CD8 T cell development: a balancing act between memory cell potential and terminal differentiation. J Immunol180: 1309–1315. 18209024
44. Coquet JM, Middendorp S, van der Horst G, Kind J, Veraar EA, et al. (2013) The CD27 and CD70 costimulatory pathway inhibits effector function of T helper 17 cells and attenuates associated autoimmunity. Immunity38: 53–65. doi: 10.1016/j.immuni.2012.09.009 23159439
45. Mackay LK, Rahimpour A, Ma JZ, Collins N, Stock AT, et al. (2013) The developmental pathway for CD103(+)CD8+ tissue-resident memory T cells of skin. Nat Immunol14: 1294–1301. doi: 10.1038/ni.2744 24162776
46. Boudousquie C, Danilo M, Pousse L, Jeevan-Raj B, Angelov GS, et al. (2014) Differences in the transduction of canonical Wnt signals demarcate effector and memory CD8 T cells with distinct recall proliferation capacity. J Immunol193: 2784–2791. doi: 10.4049/jimmunol.1400465 25127860
47. McGeachy MJ, (2013) Th17 memory cells: live long and proliferate. J Leukoc Biol94: 921–926. doi: 10.1189/jlb.0313113 24006508
48. Boyman O, Letourneau S, Krieg C, Sprent J, (2009) Homeostatic proliferation and survival of naive and memory T cells. Eur J Immunol39: 2088–2094. doi: 10.1002/eji.200939444 19637200
49. Wojciechowski S, Tripathi P, Bourdeau T, Acero L, Grimes HL, et al. (2007) Bim/Bcl-2 balance is critical for maintaining naive and memory T cell homeostasis. J Exp Med204: 1665–1675. doi: 10.1084/jem.20070618 17591857
50. Kurtulus S, Tripathi P, Moreno-Fernandez ME, Sholl A, Katz JD, et al. (2011) Bcl-2 allows effector and memory CD8+ T cells to tolerate higher expression of Bim. J Immunol186: 5729–5737. doi: 10.4049/jimmunol.1100102 21451108
51. Shi LZ, Wang R, Huang G, Vogel P, Neale G, et al. (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med208: 1367–1376. doi: 10.1084/jem.20110278 21708926
52. Fan D, Coughlin LA, Neubauer MM, Kim J, Kim MS, et al. (2015) Activation of HIF-1alpha and LL-37 by commensal bacteria inhibits Candida albicans colonization. Nat Med21: 808–814. doi: 10.1038/nm.3871 26053625
53. Croft M, (2014) The TNF family in T cell differentiation and function—unanswered questions and future directions. Semin Immunol26: 183–190. doi: 10.1016/j.smim.2014.02.005 24613728
54. Jain R, Chen Y, Kanno Y, Joyce-Shaikh B, Vahedi G, et al. (2016) Interleukin-23-Induced Transcription Factor Blimp-1 Promotes Pathogenicity of T Helper 17 Cells. Immunity44: 131–142. doi: 10.1016/j.immuni.2015.11.009 26750311
55. Murali-Krishna K, Ahmed R, (2000) Cutting edge: Naive T cells masquerading as memory cells. Journal of Immunology165: 1733–1737.
56. Bachmann MF, Beerli RR, Agnellini P, Wolint P, Schwarz K, et al. (2006) Long-lived memory CD8(+) T cells are programmed by prolonged antigen exposure and low levels of cellular activation. European Journal of Immunology36: 842–854. doi: 10.1002/eji.200535730 16552716
57. Schluns KS, Lefrancois L, (2003) Cytokine control of memory T-cell development and survival. Nat Rev Immunol3: 269–279. doi: 10.1038/nri1052 12669018
58. Aiello FB, Graciotti L, Procopio AD, Keller JR, Durum SK, (2013) Stemness of T cells and the hematopoietic stem cells: fate, memory, niche, cytokines. Cytokine Growth Factor Rev24: 485–501. doi: 10.1016/j.cytogfr.2013.10.002 24231048
59. Palazon A, Goldrath AW, Nizet V, Johnson RS, (2014) HIF transcription factors, inflammation, and immunity. Immunity41: 518–528. doi: 10.1016/j.immuni.2014.09.008 25367569
60. Doedens AL, Phan AT, Stradner MH, Fujimoto JK, Nguyen JV, et al. (2013) Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen. Nat Immunol14: 1173–1182. doi: 10.1038/ni.2714 24076634
61. Intlekofer AM, Banerjee A, Takemoto N, Gordon SM, Dejong CS, et al. (2008) Anomalous type 17 response to viral infection by CD8+ T cells lacking T-bet and eomesodermin. Science321: 408–411. doi: 10.1126/science.1159806 18635804
62. Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, et al. (2011) Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1. Cell146: 772–784. doi: 10.1016/j.cell.2011.07.033 21871655
63. Finlay DK, Rosenzweig E, Sinclair LV, Feijoo-Carnero C, Hukelmann JL, et al. (2012) PDK1 regulation of mTOR and hypoxia-inducible factor 1 integrate metabolism and migration of CD8+ T cells. J Exp Med209: 2441–2453. doi: 10.1084/jem.20112607 23183047
64. Chang JT, Wherry EJ, Goldrath AW, (2014) Molecular regulation of effector and memory T cell differentiation. Nat Immunol15: 1104–1115. doi: 10.1038/ni.3031 25396352
65. Souers AJ, Leverson JD, Boghaert ER, Ackler SL, Catron ND, et al. (2013) ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets. Nature Medicine19: 202–208. doi: 10.1038/nm.3048 23291630